Surgical Stents Market Analysis By Business Methodologies, Financial Overview And Growth Prospects Predicted By 2023

Market Research Future Published a Half Cooked Research Report on Global Surgical Stents Market Research Report.

Surgical Stents Market Highlights

Stents are tiny tube like medical devices, which are placed into blood vessels or arteries to open the blockage in the vessels. They are primarily used in the treatment of cardiac and renal diseases. A number of people are suffering from cardiac and renal diseases, and the number is increasing continuously due to changing lifestyle, and lack of exercise. The global surgical stent market is driven by increasing prevalence of cardiac & renal diseases, rising diabetic population, and continuous innovation & introduction of new stents. However, the risk of infection, long approval time and higher cost holding the growth of the market. The global surgical stent market is projected to grow at a CAGR of 7.9% during the forecast period 2017-2023.

Surgical Stents Market Segmentation:

The global surgical stents market is segmented into types, type of materials, application, and end users. On the basis of types, the market is segmented: cardiac stents, urinary stents, biliary stents, oesophageal stents, prostatic stents, and others. Cardiac stents are further segmented: self-expanding stents, balloon expanding stents, bio-engineered stents, dual therapy stents, artery stents, drug eluting stents, and others. Urinary stents are further segmented: open end stents, double pigtail stents, closed end stents, and multi loop stents. On the basis of materials, the market is segmented: metal, standard polymer, and biodegradable polymer. On the basis of applications, the market is segmented: cardiac diseases, urinary tract diseases, and others. On the basis of end users, the market is segmented into hospital, clinics, and others.

Surgical Stents Market Regional Analysis

America accounts for the largest share of global surgical stent market owing to the presence of an enormous patient population base. According to the Centers for Disease Control and Prevention, 9.3% of total America population is suffering from diabetes. Diabetes and obesity are the leading causes of cardiac and renal diseases. Due to increasing diabetic and obese population, America is witnessing rapid growth in the market. Europe has the second leading market of surgical stents which is followed by Asia Pacific. Asia Pacific is experiencing the highest growth for the surgical stents market in the globe. According to the WHO (2016), around 5% of the total Indian population is suffering from obesity. Increasing prevalence of cardiac diseases, rising obese, and geriatric population boosting the growth in Asia Pacific market. India and China dominate the market for surgical stents in Asia Pacific region.

Some of the major key player in the market are STI Laser Industries, Ltd (Israel), ELLA - CS, s.r.o. (Czech Republic), Medtronic (US), Boston Scientific Corporation (US), Laserage Technology corporation (US), amg International GmbH (Germany), Abbott (US), Angiocare (Netherlands), Meril Life Sciences Pvt. Ltd. (India), Elixir Medical Corporation (US), F. Hoffmann-La Roche Ltd. (Switzerland), B. Braun Melsungen AG(Germany), Medtronic (US), Amaranth Medical, Inc (US), Arterial Remodeling Technologies (US).

The global surgical stents market is experiencing extreme competition due to major companies are focusing on the development of biodegradable stents to overcome the disadvantages of other available stents. Some major has adopted strategies of acquisitions and strategic alliances for the growth of the market.

Boston Scientific Corporation, headquartered in the US, is a global manufacturer and developer of medical devices. The company has adopted various strategies to sustain in the competitive market, for instance, new products launch. PROMUS Element Plus Stent, REBEL Stent System, SYNERGY Stent are some of the major products of the company. In 2015, worldwide sales of the company’s drug-eluting coronary stents were $1.074 billion as compared to $1.151 billion during 2014.

Access Report Details @ https://www.marketresearchfuture.com/reports/surgical-stents-market-1044

Abbott, headquartered in US, is one of the leading healthcare company. In June 2016, FDA has approved the Absorb bioresorbable Stent for heart. This stents is completely dissolve in the body and used in the treatment of heart complications. Company’s Esprit bioresorbable vascular scaffold is under clinical trials.

Medtronic, headquartered in UK, is a world's largest standalone medical device manufacturer. In 2015 company has develop Stent Graft System System for Endovascular Repair of Thoracoabdominal Aortic Aneurysms. Earlier company’s Resolute Drug-Eluting Stent has shown a very good performance in Diabetic Patients with Heart Disease.

Dental Software Market 2020: Global Opportunities, Growth Factors And Forecast By Regions, Types, Applications And Dynamics

Dental Software Market Overview

The worldwide market for dental software is likely to expand at 8.0% CAGR (2016-2027).

Global dental software market has been growing consistently owing to the increasing need for streamlining dental procedures and managing progress in hospitals. Implementation of the dental software adds to the efficiency and productivity of the process. It aids dentists with features such as reminder service, appointment scheduling, payment, tooth charting, and others. Increasing demand for enhanced quality of services, speeding up diagnosis, increasing indulgence into unhealthy eating habits, and need for patient satisfaction drives the dental software market reasonably. Surge in oral healthcare expenditure, increasing government funding towards improving oral healthcare facilities collectively with the rising aged population globally substantially propels the growth in dental software market. Moreover, high rate of dental ailments and increasing workload on dentists have been a plus for the market growth. However, late adoption, complex software operations, and high cost of software are likely to hinder the market growth to a large extent.

Dental Software Market Segmentation

Worldwide dental software market has been segmented based on application, type, end user, and deployment.

Based on application, the market has been segmented into administrative application and clinical application. Clinical application segment has been dominating the market with 91.9% share of the global dental software market.

Based on type, the market has been segmented into patient communication software, practice management software, patient education software, dental imaging software, and treatment planning software.

Based on end user, the market has been segmented into research institutes, academics, hospitals & clinics. Hospital is the leading end user of the global dental software market. Increased patient visits in hospitals and clinics boost the hospital segment.

Based on deployment, the market has been segmented into web-based/ cloud-based model and on-premise model.

Dental Software Market Regional Analysis

Global dental software market has been segmented into the Americas, Europe, and Asia Pacific. The Americas represent the largest dental software market holding 48.35% share of the global market. Integration of the Health Information Technology for Economic and Clinical Health Act (HITECH Act) in the American healthcare system has remarkably affected the medical system in the country. HITECH came into force during February 17, 2009 when President Obama passed it as part of the American Recovery and Reinvestment Act of 2009 (ARRA), a financial stimulus bill. The HITECH Act highly encouraged the application of electronic health records (EHR) and subsidiary technology in the United States healthcare infrastructure. With extensive application of Electronic Health Record, North America has been identified as one of the key dental software markets globally. ABELDent Inc., a leading service provider in the North American dental software market confirms that the share valuation of the region is likely to increase rapidly by 2027. Early adoption of latest technologies and continuous progress in the field of medical technology boosts the market growth in this region.

Despite the increasing liberalization of the healthcare sectors, the dental market in Western Europe remains vastly fragmented and offers a prospective market for investment opportunity for strategic buyers and private equity firms from adjacent healthcare sectors. Creation and consolidation of dental chains are likely to bring substantial procurement and operational efficiencies. Dental chains in Europe are well positioned to incorporate technological developments such as 3D printing, computer-aided manufacturing (CAD/CAM), and computer-aided design which can curtail supply chains, cut the cost of bridges and crowns and pave way for a technology-oriented market.

Asia Pacific market holds a significant share in the global dental software segment and is likely to prosper at a rate of 8.8% CAGR over the forecast period. The APAC market have been identified with instances of inequal oral health distribution. Oral diseases have been found affecting the underprivileged who have limited access to health services. Delayed or denied access to dental care is owing to high cost of dental services coupled with unavailability of skilled doctors. Policymakers in the APAC market are striving hard to bridge the gap by implementing and upgrading advanced forms of technology into the market.

OBTAIN PREMIUM RESEARCH REPORT DETAILS @ https://www.marketresearchfuture.com/reports/global-dental-software-market-675

Dental Software Market Key Drivers

Global dental software market has been dominated by key players such as Medicloud, Dentimax llc., Abeldent Inc., Ace Dental Software, Carestream Health, Inc, Dexis llc, Henry Schein, Inc, Gendex Dental System, Open Dental Software Inc, Imageworks Corporation, Sirona Dental Systems, Inc, Planmeca Oy, Patterson Dental, Consult-Pro, and others.

Neonatal Intensive Care Market 2020 Overview, Segmentation, Application, Technology, Industry Challenges, Key Vendors, Drivers

Neonatal Intensive Care Market Overview

Global neonatal intensive care market is slated to exhibit a strong 5.5% CAGR over the forecast period (2018 to 2023), according to the latest research report from Market Research Future (MRFR). The global neonatal intensive care market is mainly driven by the growing awareness about infant mortality and the growing efforts from governments to bridge the gap between supply and demand in order to reduce infant mortality. Major players in the global neonatal intensive care market are profiled in the report in order to provide readers with a detailed view of the market, including the successful strategies used by leading players in the market. Major drivers and restraints of the neonatal intensive care market are also described in the report in great detail, including information on the macroeconomic factors working in the background.

The neonatal intensive care market is mainly driven by the increasing incidence of infant mortality. Due to poverty and unavailability of advanced medical care, many developing regions suffer from high rates of infant mortality, leading to widespread concern. This has led to the rapid growth of the healthcare sector in regions such as Asia Pacific, where nations with sufficient economic power to make proactive decisions in order to reduce infant mortality. This has led to a growing volume of construction of healthcare agencies such as hospitals and neonatal care units. The growing population in regions such as India, China, and the rest of Southeast Asia is also a major driver for the neonatal intensive care market in the region.

Neonatal Intensive Care Market Competitive Analysis:

Leading players in the global neonatal intensive care market include Becton Dickinson and Company, R. Bard, Philips, Teleflex Inc., Utah Medical, Cook Medical, Medtronic, B. Braun Melsungen AG, AngioDynamics Inc., and Vygon (UK) Ltd.

In September 2019, St. Peter’s Health and Bozeman Health, leading healthcare providers in Montana, announced a collaboration agreement to work on a new neonatal intensive care unit. The growing population of the surrounding region, a major economic center of the state, has necessitated the development of new, developed technologies to serve the growing need. The unit is also expected to feature telehealth facilities.

Neonatal Intensive Care Market Segmentation:

The global neonatal intensive care market is segmented on the basis of product type, end use, and region.

By product type, the global neonatal intensive care market is segmented into infant warmers, incubators, respiratory devices, neonatal monitoring devices, convertible warmer & incubators, phototherapy equipment, catheters, and others. The infant warmers segment is further sub-segmented into electric and non-electric infant warmers. The neonatal monitoring devices segment is further classified as cardiopulmonary monitor, blood pressure monitor, pulse oximeters, capnographs, and others.

By end use, the global neonatal intensive care market is segmented into hospitals, childcare clinics, and others.

OBTAIN PREMIUM RESEARCH REPORT DETAILS @ https://www.marketresearchfuture.com/reports/neonatal-intensive-care-market-7513

Neonatal Intensive Care Market Regional Analysis:

North America and Europe are biggest revenue-generating regions in the global neonatal intensive care market. Widespread development of medical technology and high awareness regarding the various conditions that can affect infants and bring about infant diseases and mortality have led to strong development of the neonatal intensive care market in these regions over the years. Developing countries have mainly suffered from a lack of advanced device technology, whereas the strong presence of the industrial manufacturing sector in Europe and North America has allowed the neonatal intensive care market to flourish in these regions. Growing investment in the private healthcare sector is likely to result in further product advances in the neonatal intensive care market in these two regions, leading to steady growth of the market. Technological development in the neonatal intensive care market is likely to be a major strength of the market in North America and Europe.

Widespread availability of government-sponsored healthcare reimbursement schemes in Europe has enabled widespread availability of neonatal intensive care units. This is likely to be a major driver for the neonatal intensive care market in Europe over the forecast period, as the region has one of the highest rates of healthcare coverage in the world.

Vascular Patches Market – Industry Challenges, Key Vendors, Drivers, Trends, Overview, Segmentation, Application, Technology

Vascular Patches Market Analysis

The global vascular patches market is poised to touch USD 6.1 billion at a notable 4.1% CAGR over the predicted years (2018-2023). Vascular patches are utilized in vascular surgeries for closing sutures. In every surgical procedure, the primary closure of sutures needs to be done effectively. Vascular patches are made from synthetic or biological materials and are characterized through excellent biocompatibility. Of the different types, it is the biological vascular patches that are most widely used owing to its various advantages such as excellent biocompatibility, low suture line bleeding, minimum infection rate and ease in use.

There are plentiful factors that is boosting the growth of the vascular patches market. These factors as per the Market Research Future (MRFR) report include rapidly increasing geriatric population, prevalence of vascular diseases, growing number of vascular surgeries being performed, growing use of biological patches, need for minimally invasive surgeries and increasing product launches and research and development investments. On the contrary, scarcity of skilled professional, mishandling, decrease in carotid endarterectomy surgeries owing to low preference are factors that may restrict the growth of the vascular patches market.

Vascular Patches Market Segmentation

MRFR report provides an extensive segmental analysis of the vascular patches market on the basis of application, material and end-user.

Based on material, it is segmented into synthetic vascular patches and biologic vascular patches. Of these, the biologic vascular patches will have the maximum share in the market over the predicted years followed by synthetic vascular patches that will grow at the fastest pace.

Based on application, the vascular patches market is segmented into open repair of abdominal aortic aneurysms vascular bypass surgery and carotid endarterectomy. Of these, carotid endarterectomy will dominate the market followed by open repair of abdominal aortic aneurysms vascular bypass surgery which will grow at the fastest rate.

Based on end-user, it is segmented into ambulatory surgical centers, hospitals and clinics and others. Of these, hospitals and clinics will rule the market followed by ambulatory surgical centers that will grow at the fastest pace.

Vascular Patches Market Regional Analysis

By region, the vascular patches market covers growth opportunities and latest trends across North America, Europe, Asia Pacific and Middle East and Africa. Of these, North America will domineer the market over the predicted years and is expected to expand at a substantial CAGR. The increasing occurrence of cardiovascular issues in Canada and the US, growing population and increasing per capita healthcare spending will boost the market growth in this region. Also, the rapid uptake of latest devices and technologies in the surgical procedure and the presence of key manufacturers is again boosting the market growth. The vascular patches market in Europe will have the second major share due to the resurging economy, growing awareness regarding vascular patches and procedure advancements and increasing per capita healthcare expenses. The vascular patches market in the APAC region will grow at the fastest pace over the predicted years owing to growing healthcare sector in India and China, increasing geriatric populace, growing awareness regarding healthcare and rising incidence of people suffering from various chronic coronary diseases.

OBTAIN PREMIUM RESEARCH REPORT DETAILS @ https://www.marketresearchfuture.com/reports/vascular-patches-market-6652

Vascular Patches Market Key Players

Leading players profiled in the vascular patches market include Baxter International Inc. (U.S.), Edwards Lifesciences Corporation (U.S.), Labcor Laboratórios Ltda (Brazil), Admedus (Australia), CryoLife, Inc. (U.S.), W. L. Gore & Associates, Inc. (US), LeMaitre Vascular, Inc. (U.S.), Maquet (Germany), B. Braun Melsungen AG (Germany), Terumo Corporation (Japan), C.R. Bard, Inc. (U.S.) and others.

April 2019- Tel Aviv University researchers have come up with the world’s first ever 3D printed heart that is perfectly functioning, anatomically, biochemically, cellular and immunologically matched. The heart will be vascularized and supplied through the patient’s blood vessels and created from the own cells of the patient. This new study is called “3D Printing of Personalized Thick and Perfusable Cardiac Patches and Hearts” and throws light on the fact that should a 3D printed heart be made from the own cells of the patient and transplanted, there can be higher transplant success.

Ultrasound Probe Disinfection Market Trends, Industry Forecast, Applications, Growth Drivers, Trends & Demands - Global Forecast To 2023

Ultrasound Probe Disinfection Market Overview:

Global Ultrasound Probe Disinfection Market can surpass an estimated valuation of USD 819.1 million by 2023 all the while acquitting a healthy CAGR of 21.1% between 2017 and 2023, which is considered in the market as the forecast period.

Ultrasound probe disinfection finds robust application in sterilizing or cleaning instruments and devices used that are generally used in hospitals and other medical facilities. The disinfectants are targets any kind of bacterial contamination. This, resultantly, is triggering the growth of the ultrasound probe disinfection market. 

The driving factors impacting the market growth for ultrasound probe disinfection are surge in ultrasound imaging procedures, better awareness on how to maintain a sterile, safe, and disinfectant environment in hospitals and incorporate other technologically-advanced machines. Growth in number of patients registering for various imaging procedures can also ensure a better hike for the global ultrasound probe disinfection market.

On the flip side, its high cost can be a market deterrent. But rising demand for safe practices can ensure strong market incorporation of the technology.

Ultrasound Probe Disinfection Market Segmentation:

The global market for the ultrasound probe disinfection can be segmented into process, probe type, product, and end-user.

By product, the global market for ultrasound probe disinfection can be segmented into service, instrument, and consumables. The instrument can be segmented into manual reprocessors/soaking stations, UV-C disinfectors, automated probe reprocessors, and ultrasound transducer storage cabinets. The consumables can be assessed on the basis of type of disinfectants, formulation, and detergents. By formulation, the disinfectants segmentation includes disinfectant liquids, disinfectant wipes, and disinfectant sprays. By type, the consumables segment comprises high-level disinfectants and intermediate/low-level disinfectants. By detergents, the segmentation holds enzymatic detergents and non-enzymatic detergents.

By probe type the market for ultrasound probe disinfection includes convex transducers, linear transducers, endocavitary transducers, transesophageal echocardiography transducers (TEE), phased array transducers, and other.

By probe type, the market report for ultrasound probe disinfection includes high-level disinfection and intermediate/low-level disinfection.

By end-user, the market for ultrasound probe disinfection integrates diagnostic centers, hospitals & clinics, academic & research institutes, ambulatory care centers, and others.

Ultrasound Probe Disinfection Market Regional Analysis:

North America has a better opportunity to register better market growth in the coming years. This would grow due to the substantial expenditure made by various governments and private investors to take the global market forward. Government regulations in the region is fast becoming stringent to ensure better safety for patients. This is also to ensure that the region witnesses better cleanliness and sanitation processes.

Europe has posited itself on the second spot and is known for its presence in the global market. These have become possible due to their substantial investment in research and development projects. Various private investors are showing a keen interest in the regional market and can easily promote the global market.

New healthcare developments and increasing funding are expected to take the regional market for the Asia-Pacific forward. Constant hike in various technological funding is expected to trigger the global market ahead.

However, the regional market in the Middle East & Africa (MRFR) can move at a sluggish pace with various countries showing intense market contributions. Africa has several poor economies that can deter the global market. These companies are known for their lack of infrastructure but it can be managed by the Middle Eastern part due to their hike in the expenditure.

OBTAIN PREMIUM RESEARCH REPORT DETAILS @ https://www.marketresearchfuture.com/reports/ultrasound-probe-disinfection-market-6642

Ultrasound Probe Disinfection Market Competitive Landscape:

Companies taking the global market ahead are implementing several strategic moves to cement their own market position and trigger holistic growth for the market. These companies are Nanosonics (Australia), STERIS (UK), Ecolab (US), Tristel (UK), Advanced Sterilization Products (US), Schülke & Mayr (Germany), Germitec (France), Virox Technologies (Canada), CIVCO Medical Solutions (US), CS Medical (US), Parker Laboratories (US), and Metrex Research (US). MRFR profiled these companies to get a better understanding of the market in the future. This would also help in the understanding of various trends that can trigger market growth.

In June 2019, CS Medical announced that they have received clearance for the new Class II medical device TEEClean Automated TEE Probe Cleaner Disinfector from the US FDA. This is the first-of-its-kind in the US.  

Electrical Hospital Beds Market Review, Future Growth, Global Survey, In-Depth Analysis, Share, Key Findings, Company Profiles, Development Strategy, Emerging Technologies, Trends And Forecast By 2023

Electrical Hospital Beds Market – Overview

Increased focus on patient comfort is leading to increased investment in equipment, such as electrical hospital beds. Reports that evaluate the healthcare industry have been presented by Market Research Future, which creates reports on industry verticals that assess the market development and prospects. The Electrical Hospital Beds Market is anticipated to advance with a 7.25% CAGR in the upcoming period.

Increased incorporation of ergonomically engineered devices to offer utmost comfort and aid in enhancing recovery time is motivating the market for electrical hospital beds. Moreover, the growing focus on patient rehabilitation is expected to further strengthen the expansion of the electrical hospital beds market in the approaching period. The growing presence of established competitors in the market is anticipated to boost the electrical hospital beds market in the future.

Electrical Hospital Beds Market Segmental Analysis

The segmental study of the electrical hospital beds market is carried out on the basis of type, treatment, applications, end use, and region. Based on type, the electrical hospital beds market is segmented into fully automatic and semi-automatic. On the basis of treatment, the electrical hospital beds market is segmented into critical care, acute care, and long-term care. Based on applications, the electrical hospital market comprises of intensive care, general purpose, delivery/birthing, psychiatric care, bariatric, pediatric, pressure relief, and others. The end-user segment of the electrical hospital bed market comprises of reproductive care centers, hospitals and clinics, dentistry, home care, and others. Based on the regions, the electrical hospital beds market is segmented into the Middle East, the Americas, Asia Pacific, Europe, and Africa.

Electrical Hospital Beds Market Detailed Regional Analysis    

The regional examination of the electrical hospital beds market has been segmented into the Middle East, the Americas, Asia Pacific, Europe, and Africa. The European region is the principal market for electrical hospital beds and had accounted for 34% portion of the global market in 2017. The presence of sophisticated healthcare infrastructure and better emphasis on patient health and comfort in the region is driving the market. Nations such as France, the U.K., and Germany are important contributors to the European region market, which can reach a valuation of USD 906.4 Mn by the end of 2023. The Americas region is the next principal market for electrical hospital beds motivated by elevated healthcare expenditure in strong economies such as the US and Canada. Moreover, the APAC market is estimated to display speedy progress over the forecast period. Moreover, increased investment on the progress of healthcare infrastructure, the expansion of medical tourism, and accessibility to a massive patient pool generates promising growth prospects for market development.

Electrical Hospital Beds Market Competitive Analysis

The disequilibrium noticed in the forces that are backing the growth of the market is expected to lead to a relatively slow pace of the growth. The enhancement of the distribution channels is projected to motivate market growth relatively. The conducive nature of the monetary and fiscal policies is likely to lead to solid growth in the market. Moreover, the rise in International transactions is anticipated to bolster the expansion of the market considerably. The positive effect exerted by governments in the development of the market is expected to guide the market towards sound progress in the coming years. The global economies are reacting to the market forces by implementing favorable policies and cutbacks so as prevent a slowdown in the progress of the market. The changes in the income levels globally are contributing to the growth of the market. The rise in individual discretionary spending is anticipated to lead to the progress of the market.

OBTAIN PREMIUM RESEARCH REPORT DETAILS @ https://www.marketresearchfuture.com/reports/electrical-hospital-beds-market-6552

The noteworthy contenders in the electrical hospital beds market are Span America Medical System, Inc. (U.S.), Stryker Corporation (U.S.), Famed Zywiec Sp.zo.o. (Poland), Merivaara Corporation (Finland), Gendron, Inc. (U.S.), ArjoHuntleigh (Sweden), Amico Group of Companies (Canada), Midmark Corporation (U.S.), Linet spol.s.r.o. (Czech Republic), Paramount Bed Holding Co., Ltd. (Japan), Invacare Corporation (U.S.), Hill Room Holding (U.S.), Getinge AB (Sweden), Medline Industries, Inc. (U.S.), and Malvestio Spa (Italy).

Carcinoid Tumor Market 2020 Global Analysis With Focus On Opportunities, Development Strategy, Future Plans, Competitive Landscape And Trends By Forecast 2023

Market Research Future published a half-cooked research report on global carcinoid tumor market. 

Carcinoid Tumor Market Highlights

Carcinoid tumor is a type of the neuroendocrine tumor. The most common site of carcinoid tumors is the GI (gastrointestinal) tract and the lungs. However, it can also be developed in pancreas, testicles, and ovaries. The increasing prevalence of the carcinoid tumor is expected to drive the market growth. According to the American Society of Clinical Oncology (ASCO) in 2016, approximately 8,000 adults in the US were diagnosed with a carcinoid tumor in their GI tract. Moreover, it was also estimated that each year approximately 4,000 adults in the US are diagnosed with a carcinoid tumor in their lung. Moreover, growing geriatric population along with rising healthcare expenditure is likely to boost the market growth during the forecast period. However, lack of awareness, high treatment cost and related side effects may hamper the market growth during the forecast period. 

Carcinoid Tumor Market Segmentation

Global carcinoid tumor market is segmented on the basis of site, diagnosis, treatment, and end users.

On the basis of the site, the market is segmented into gastrointestinal, lung, and others. Furthermore, the gastrointestinal segment is sub-segmented into rectum, small intestine, appendix, and others. Lung segment is sub-segmented into typical, atypical, and others.

On the basis of the diagnosis, the market is segmented into serology, imaging, biopsy, and others. The serology segment is sub-segmented into blood test, urine test, molecular test, and others. The imaging segment is sub-segmented into X-ray, CT scan, PET scan, and others.

On the basis of the treatment, the market is segmented into surgery, chemotherapy, radiotherapy, and others. The surgery segment is sub-segmented into local excision, radiofrequency ablation (RFA), and others.

On the basis of the end users, the market is segmented into hospitals & clinics, academic institutes, research organization, and others.

Carcinoid Tumor Market Regional Analysis

America dominates the global carcinoid tumor market owing to a well-developed healthcare sector and huge patient population. Apart from this, increasing healthcare expenditure and presence of developed economies like the U.S. and Canada within the region have boosted the growth of the market in America.

Europe is the second leading market across the globe, which is followed by Asia Pacific owing to availability of funds for research, huge patient population, and strong government support for research & development. According to the National Health Service in 2015, each year about 1,200 people are diagnosed with carcinoid tumor in the UK.

Asia Pacific is the fastest growing region in the market due to the presence of a huge patient population and continuously developing economies like India and China, which have rising healthcare expenditure. Moreover, favorable governmental policies and the presence of huge opportunity in the untapped market within the region are likely to fuels the market growth during the forecast period. 

On the other hand, the Middle East & Africa holds the least share in the global carcinoid tumor market due to presence of poor economy, especially, in Africa region. Majority of the market of this region is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure. The presence of developed economies like Qatar, Saudi Arabia, Dubai, and others within the region fuels the market growth.

Access Report Details @ https://www.marketresearchfuture.com/reports/carcinoid-tumor-market-4813

Carcinoid Tumor Market Key Players

Some of the key players in the global carcinoid tumor market are Novartis AG (Europe), Amgen Inc. (U.S.), Boehringer Ingelheim GmbH (Europe), AVEO Pharmaceuticals, Inc. (U.S.), Chiasma, Inc. (U.S.), Aegis Therapeutics, LLC (U.S.), CRINETICS PHARMACEUTICALS (U.S.), Delcath Systems Inc. (U.S.), Exelixis, Inc. (U.S.), and others.

Companion Animal Healthcare Market 2020 Size, Share, Trends, Regional Analysis And Segmentation By Key Companies

Companion Animal Healthcare Market Analysis 

The global companion, animal healthcare market, is predicted to touch USD 20 billion at a 9.6% CAGR over the forecast period (2017-2023), as per the latest Market Research Future (MRFR) report. Companion animals are used for amusement, company, extrovert display, psychological support, and other functions which humans require for sharing with animals. A yearly veterinary checkup is one of the finest means of keeping the pet healthy. 

Various factors are propelling the companion animal healthcare market growth. These factors, as stated by the MRFR report, include growing pet adoption across the world, increasing government initiatives for animal health, growing advancements in technology in animal healthcare, and increasing nuclear families that have accelerated the trend of pet ownership. Additional factors pushing market growth include growing investments made by key players for developing advanced pet care solutions, increasing awareness about animal cruelty, advances in animal vaccines and health medicines, and increased types of medical treatment. 

Companion Animal Healthcare Market Segmentation 

The Market Research Future report provides a wide segmental analysis of the companion animal healthcare market based on end users, diagnostic tests, and product. 

Based on product, the companion animal healthcare market is segmented into vaccines, pharmaceuticals, and feed additives. The feed additives segment is again segmented into medicinal feed additives and nutritional feed additives. The nutritional feed additives segment is further segmented into vitamins, minerals, and proteins, and medicinal feed additives are further segmented into probiotics and prebiotics, immune-modulators, enzymes, hormones, and others. The pharmaceutical products segment is further segmented into anti-inflammatories, antibiotics, and anti-infectives. Of these, the pharmaceutical products segment will have the largest share in the market over the forecast period. This is owing to the rising prevalence of food-borne diseases, brucellosis as well as other zoonotic diseases which are hazardous to animals. 

Based on diagnostic tests, the companion animal healthcare market is segmented into molecular diagnostics, immunodiagnostic tests, diagnostic imaging, and others. Of these, the diagnostics imaging segment will dominate the market over the forecast period. This is owing to rising zoonotic infections that is boosting the need for establishing point-of-care testing and diagnostics laboratories. 

Based on end users, the companion animal healthcare market is segmented into home care, veterinary clinics, and veterinary hospitals. Of these, the veterinary clinics and veterinary hospitals will lead the market over the forecast period. This is owing to the accessibility of a huge variety of diagnostic options. 

Companion Animal Healthcare Market Regional Analysis 

Based on the region, the companion animal healthcare market report covers the latest trends and growth opportunities across the Asia Pacific, Europe, the Americas, and the Middle East and Africa. Of these, the Americas will spearhead the market over the forecast period. This is owing to the availability of a huge variety of animal health products. 

The companion animal healthcare market in Europe is predicted to have the second-largest share in the market over the forecast period. This is due to an increase in pet ownership on account of tax benefits offered by the government. 

The companion animal healthcare market in the APAC region is predicted to have a positive and steady growth over the forecast period. This is owing to the rising awareness about animal cruelty that has influenced people awareness as well as ideologies towards animals. 

The companion animal healthcare market in the Middle East and Africa is predicted to have a steady growth over the forecast period. This is owing to high growth opportunities on account of financial improvement and an associated increase in disposable income. 

OBTAIN PREMIUM RESEARCH REPORT DETAILS @ https://www.marketresearchfuture.com/reports/companion-animal-healthcare-market-1168

Companion Animal Healthcare Market Key Players 

Leading players profiled in the companion animal healthcare market report include Boehringer Ingelheim (Germany), Perrigo Company plc (Ireland), Vetoquinol S.A. (France), Bayer Animal Health (Germany), Elanco Animal Health (US), Merial (France), Virbac Animal Healthcare (France), Ceva Animal Healthcare (UK), Merck and Co., Inc. (US), and Zoetis Animal Healthcare (US), among others. Key players have acquired several strategies to gain a competitive edge in the market. This include product launch, expansion, partnership, collaboration, and acquisition. 

December 2018: August Equity has acquired Hallmarq Veterinary Imaging Ltd., a specialist in advanced diagnostics for equine as well as companion animals.

Pharmacogenomics Market Analysis 2020: Key Findings, Regional Analysis, Top Key Players Profiles, Size

Pharmacogenomics Market Overview

Pharmacogenomics or Pharmacogenetics is a study that refers to the genes and their impact on the way human body responses to the medication. The study combines pharmacology, the science of medicines and genomics, the study of genes and their functions to develop effective, safe drugs and doses, personalized for a typical genetic makeup (person’s genetic structure). The key objective of this study is to help doctors to pick the best-suited drugs and dosages for each person.

The concept basically, includes classifying individuals into the groups or categories that are uniquely prone to a particular disease or responsive to a specific treatment. Pharmacogenomics will play an essential role in revitalizing some drugs that were deemed ineffective and abandoned during the initial phases of development. Attributing to the increasing awareness of drug safety, the pharmacogenomics market is increasing rapidly.

Acknowledging the exponential growth, the market perceives currently and the potential of the market to grow in the future; Market Research Future (MRFR), recently published a market forecast. In its analysis MRFR asserts that the global Pharmacogenomics will grow exponentially by 2023, registering a CAGR of ~5.8% throughout the forecast period (2017 – 2023).

Factors such as the increased utilization of medication revelation processes, growing interest & popularity for customized drugs, expanding security in treatment, and the success ratio of adequacy trials are contributing to the market growth.

Advent of healthcare technologies and rapid advances like PCR (Digital Polymerase Chain Reaction), GenX sequencing, and HTS (High Throughput Screening), are fostering the growth of the global market of Pharmacogenomics.

Furthermore, factors such as the rising demand for diagnostic tests led by the growing emphasis of patients on pre-diagnosis treatments alongside the increasing genetic disorders & mutational diseases are expanding the market rapidly.  The government initiatives and investments in R&D programs are providing impetus to the market growth.

Adverse medicine reactions are a prominent cause of hospitalizations and deaths. With the help of Pharmacogenomics, researchers have found a way to use genetic differences to predict if a medication can be useful for a particular person to prevent drug reactions. As Pharmacogenomics is in its embryonic stage, currently its use is quite limited. Nevertheless, the new approaches that are on its way for clinical trials are expected to support market growth.

Soon, Pharmacogenomics will perceive the development of personalized drugs that can treat a wide range of health problems, such as cardiovascular disease, Alzheimer's disease, cancer, cardiovascular disease, asthma, and HIV/AIDS. 

Global Pharmacogenomics Market – Segmentations

For ease of understanding, the market is segmented into four key dynamics: -

 By Technology: Microarray, Polymerase Chain Reaction and Sequencing (Sanger, Pyrosequencing, and Next-generation sequencing, others), among others.  

By Application: Oncology (Breast Cancer, Lung Cancer, others), Cardiology, and Neurological Disorders among others.

By End-users: Hospitals, Research Organizations, and Academic Institute among others. 

By Regions: North America, Asia Pacific, Europe, and the Rest-of-the-World. 

Global Pharmacogenomics Market – Regional Analysis

The North American region, heading with the favorable reimbursement scenario and higher expenditure on healthcare would continue its dominance over the global market of Pharmacogenomics market. Additionally, the increasing prevalence of cardiovascular diseases in the region alongside the well-spread awareness towards the benefits of a Pharmacogenomics is boosting the growth of the market. The rapid uptake of new medical technologies primarily in the US is also a dominant driving force leading the Pharmacogenomics market in the region.

The Pharmacogenomics market in the European region accounts for the second-largest market, globally. Well-penetrated healthcare sector and the resurging economy in the region are two of the key driving forces behind the growth of the European Pharmacogenomics market. Moreover, factors such as the increased funding and government support for the R&D activities and the presence of a large patient pool in the region drive the growth of the regional market.

The Asia Pacific Pharmacogenomics market is rapidly emerging as a profitable market globally. Factors such as the rapidly developing economy and the proliferating healthcare sector in the region are some of the major factors driving the Pharmacogenomics market in the region. Rapidly emerging countries such as China and India backed by the vast population and the large unmet clinical needs in these countries predominantly drive the regional Pharmacogenomics market.

Besides, the growing penetration of healthcare insurance is projected to contribute to the growth of the regional market significantly.  Simultaneously, Vietnam, Thailand, and Malaysia among the other South East Asian countries are expected to drive the Pharmacogenomics market in the Asia Pacific region. 

Global Pharmacogenomics Market – Competitive Analysis

Highly competitive, the global Pharmacogenomics market appears to be fiercely competitive due to the presence of several well-established and startup companies operating in the market. These players invest heavily in R&D and clinical trials to develop effective drugs. These players incorporate strategic initiatives such as collaboration, acquisition, expansion, technology launch, and strategic partnership.

OBTAIN PREMIUM RESEARCH REPORT DETAILS @ https://www.marketresearchfuture.com/reports/pharmacogenomics-market-1177

Pharmacogenomics Market Major Players

Key players leading the global pharmacogenomics market include 23andMe, Inc. (US), Pathway Genomics (US), Myriad Genetics, Inc. (US), GeneDx. (US), Future Science Group (US), GeneTech (US), Assurex Health, Inc. (US), and Teva Pharmaceutical Industries Ltd. (Israel) among others.

Pharmacogenomics Industry/Innovation/ Related News:

March 26, 2019 --- Murrieta Genomics (the US), a leading global provider of next-generation sequencing technology and Alliance Research Centers (the US), a comprehensive clinical research site management organization announced their partnership to offer genomic sequencing services as additional service to participants and trial sponsors.

These services are aiming at enabling utilization of genomic sequencing data alongside the clinical trial information to inform sponsors of clinical trial results better while enhancing the cumulative trial information available to the industry and regulators.

Pharmacogenomics will continue into the clinical practice better matching treatment with the patients while saving a considerable cost. Thereby increasing the overall efficiency of a given treatment and reducing the chance of a costly adverse event.

Enteral Feeding Devices Market Future Insights, Market Revenue And Threat Forecast By 2023

Enteral Feeding Devices Market Overview

Global enteral feeding devices market is expected to exhibit a strong 6.1% CAGR over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MRFR). The global enteral feeding devices market is profiled in detail in the report, which provides a comprehensive overview of the market’s leading drivers and restraints as well as the leading players operating in the market. The enteral feeding devices market was valued at USD 2,302.4 million in 2017.

Enteral feeding devices are used to feed people who, permanently or temporarily, have lost the ability to feed themselves due to the disease or disorder. Enteral feeding devices are used to directly deliver nutrients into some part of the small intestine or stomach, so that at-risk patients can be fed under complete supervision. Enteral feeding devices also allow doctors to monitor and manage the temporary nutrition of specific individuals in order to make sure they are being fed as much and what they should be fed, considering specific diseases and disorders. The growing geriatric population around the world is likely to be a major driver for the global enteral feeding devices market over the forecast period, as the geriatric population is likely to be a major consumer of technologies that allow them to be fed without the hassle of physically feeding themselves. The growing number of geriatric individuals suffering from neurodegenerative diseases is also likely to be a major driver for the global enteral feeding devices market.

Growing prevalence of cancer, gastrointestinal diseases, and neurological disorders is likely to be a major driver for the global enteral feeding devices market over the forecast period. Cancer patients often need to be monitored for long periods of time, in addition to requiring extensive monitoring of their dietary patterns, as rehabilitation from cancer can be highly affected by dietary imbalances. This has driven the demand for enteral feeding devices in the rehabilitation phase of cancer and other patients. The growing concern about infant mortality and the increasing efforts to prevent the same are also likely to be a key driver for the global enteral feeding devices market over the forecast period.

Enteral Feeding Devices Market Competitive Analysis:

Leading players in the global enteral feeding devices market include Vygon SA, Halyard Health Inc., Moog Inc., CONMED Corporation, Nestle, Danone Nutricia, Fresenius Kabi AG, Becton Dickinson and Company, Boston Scientific Corporation, Abbott Laboratories, B. Braun Melsungen AG, Cook Medical, and Medtronic plc. Major players in the global enteral feeding devices market are likely to focus on developing products that fit regulatory standards and enable steady growth for the company in the market. The growing scope for the medical devices sector in Asia Pacific is likely to be a key factor for the global enteral feeding devices market over the forecast period.

Enteral Feeding Devices Market Segmentation:

The global enteral feeding devices market has been segmented on the basis of product, age group, indication, end user, and region. 

By product, the market has been segmented into enteral feeding tubes, enteral feeding pumps, enteral syringes, administration sets, and consumables. The enteral feeding tubes segment is further categorized into enterostomy feeding tubes, nasoenteric feeding tubes, and oroenteric feeding tubes. The enterostomy feeding tubes segment is additionally divided into gastrostomy tubes, jejunostomy tubes, and gastrojejunostomy tubes. The nasoenteric feeding tubes segment is further classified into nasogastric feeding tubes, nasojejunal feeding tubes, and nasoduodenal feeding tubes. The enteral feeding pumps segment is expected to dominate the market throughout the forecast period due to low risk of complications with the use of feeding pumps, enhanced portable pump designs, and the increasing adoption of pumps in hospitals and home care settings.

On the basis of age group, the market has been divided into adults and pediatrics. 

By indication, the market has been classified into cancer, gastrointestinal diseases, diabetes, neurological disorders, hypermetabolism, and others. The cancer segment is further categorized into gastrointestinal cancer, head & neck cancer, liver cancer, pancreatic cancer, esophageal cancer, and others. 

Based on end user, the market has been categorized into hospitals, home care settings, and ambulatory surgery centers (ASCs). 

OBTAIN PREMIUM RESEARCH REPORT DETAILS @ https://www.marketresearchfuture.com/reports/enteral-feeding-devices-market-7828

Enteral Feeding Devices Market Regional Analysis:

The Americas dominates the global enteral feeding devices market, followed by Europe. Asia Pacific is also likely to grow at a high CAGR over the forecast period.